StonvexLoading…
StonvexStonvexStonvexCore line items from AVGO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-01 | Annual 2025 2025-11-02 | Q3 2025 2025-08-03 | Q2 2025 2025-05-04 |
|---|---|---|---|---|
Revenue | $19.31B | $63.89B | $45.87B | $29.92B |
Operating Income | $8.56B | $25.48B | $17.98B | $12.09B |
Net Income | $7.35B | $23.13B | $14.61B | $4.96B |
EPS (Diluted) | $1.50 | $4.77 | $3.02 | $2.17 |
Total Assets | $169.90B | $171.09B | $165.62B | $164.63B |
Total Liabilities | $90.03B | $89.80B | $92.34B | $95.04B |
Cash & Equivalents | $14.17B | $16.18B | $10.72B | $9.47B |
Free Cash Flow OCF − CapEx | $8.01B | $26.91B | $19.45B | $12.42B |
Shares Outstanding | 4.74B | 4.74B | 4.72B | 4.70B |